CD101: A New Long-Acting Echinocandin
David Andes, MD, shares the half-life and dosing intervals for a new long-acting echinocandin.
David Andes, MD, professor and chief of infectious disease at the University of Wisconsin, shares the half-life and dosing intervals for a new long-acting echinocandin.
Recent Videos
Related Content
